Paroxysmal nocturnal hemoglobinuria screening: Difference between revisions
Jump to navigation
Jump to search
Line 8: | Line 8: | ||
** Cytopenia | ** Cytopenia | ||
** Suspected Myelodysplasia | ** Suspected Myelodysplasia | ||
** Negative direct coombs test hemolytic anemia | |||
** Refractory anemia | |||
** Aplastic anemia | |||
** Unexplained thrombosis | |||
==References== | ==References== |
Revision as of 17:19, 13 August 2018
Paroxysmal nocturnal hemoglobinuria Microchapters |
Differentiating Paroxysmal nocturnal hemoglobinuria from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Paroxysmal nocturnal hemoglobinuria screening On the Web |
American Roentgen Ray Society Images of Paroxysmal nocturnal hemoglobinuria screening |
Directions to Hospitals Treating Paroxysmal nocturnal hemoglobinuria |
Risk calculators and risk factors for Paroxysmal nocturnal hemoglobinuria screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Screening
- According to the American society of hematology, screening for paroxysmal nocturnal hemolglobinuria is recommended among patients with:
- Cytopenia
- Suspected Myelodysplasia
- Negative direct coombs test hemolytic anemia
- Refractory anemia
- Aplastic anemia
- Unexplained thrombosis